MIR203A, microRNA 203a, 406986

N. diseases: 237; N. variants: 1
Disease: Malignant neoplasm of stomach ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 AlteredExpression disease BEFREE Upregulation of miR-203a attenuated the repressive effects of AWPPH on GC cell proliferation and invasion. 31489578 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 AlteredExpression disease BEFREE Moreover, the low level of miR-203 was associated with increased expression of annexin A4 in GC tissues and cell lines. 30837034 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 AlteredExpression disease BEFREE <b>Results:</b> miR-203 expression was down-regulated and ZEB1 mRNA level was up-regulated in GC. 31440062 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 AlteredExpression disease BEFREE The purpose of this study was to detect the biological function and regulation of miR-99b-5p and miR-203a-3p in gastric cancer (GC). 29973668 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 Biomarker disease BEFREE To explore function of UCA1-miR-203-ZEB2 axis may provide an informative biomarker of malignancy and a highly selective anti-GC therapeutic target. 30464170 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 Biomarker disease BEFREE Our data validate an important clinical significance of miR-203 in gastric cancer, and reveal that it might be a potential prognostic factor for gastric cancer. 29033185 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 AlteredExpression disease BEFREE Expression of microRNA-203 (miR-203) has been reported to decrease in GC. 28269747 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 Biomarker disease BEFREE Collectively, the results indicated that miR-203a may function as a tumor suppressor in GC by targeting E2F3. 29344215 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 Biomarker disease BEFREE Serum miR-203 has the potential to serve as a noninvasive biomarker for prognosis and to predict metastasis in patients with GC. 26233325 2016
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach 		0.100 Biomarker disease BEFREE MiR-203 as a tumor biomarker suppresses GC growth through targeting the PIBF1/Akt signaling, suggesting that it may have the important therapeutic potential for the treatment of GC. 26980572 2016